Strategies to treat protein-losing enteropathy

Fontan, 1971, Surgical repair of tricuspid atresia, Thorax, 26, 240, 10.1136/thx.26.3.240 Gentles, 1997, Fontan operation in 500 consecutive patients: Factors influencing early and late outcome, J Thorac Cardiovasc Surg, 114, 376, 10.1016/S0022-5223(97)70183-1 Hsu, 1997, Outcome after the single-stage, nonfenestrated Fontan procedure, Circulation, 96, II-335 Petrossian, 1999, Early results of the extracardiac Fontan operation, J Thorac Cardiovasc Surg, 117, 688, 10.1016/S0022-5223(99)70288-6 Fontan, 1990, Outcome after a “perfect” Fontan operation, Circulation, 81, 1520, 10.1161/01.CIR.81.5.1520 Crupi, 1980, Protein-losing enteropathy after Fontan operation for tricuspid atresia (imperforate tricuspid valve), Thorac Cardiovasc Surg, 28, 359, 10.1055/s-2007-1022109 Hess, 1984, Protein-losing enteropathy after Fontan operation, J Thorac Cardiovasc Surg, 88, 606, 10.1016/S0022-5223(19)38299-6 Davis, 1994, Enteric protein loss after the Fontan operation, Mayo Clin Proc, 69, 112, 10.1016/S0025-6196(12)61035-0 Feldt, 1996, Protein-losing enteropathy after the Fontan operation, J Thorac Cardiovasc Surg, 112, 672, 10.1016/S0022-5223(96)70051-X Mertens, 1998, Protein-losing enteropathy after the Fontan operation: An international multicenter study. PLE Study Group, J Thorac Cardiovasc Surg, 115, 1063, 10.1016/S0022-5223(98)70406-4 Coon, 2001, Thrombus formation after Fontan operation, Ann Thorac Surg, 71, 1990, 10.1016/S0003-4975(01)02472-9 Jahangiri, 1997, Coagulation factor abnormalities after the Fontan procedure and its modifications, J Thorac Cardiovasc Surg, 113, 989, 10.1016/S0022-5223(97)70283-6 Florent, 1981, Intestinal clearance of alpha 1 antitrypsin. A sensitive method for the detection of protein-losing enteropathy, Gastroenterology, 81, 777, 10.1016/0016-5085(81)90506-0 Hill, 1981, Fecal clearance of alpha 1-antitrypsin: A reliable measure of enteric protein loss in children, J Pediatr, 99, 416, 10.1016/S0022-3476(81)80332-0 Thorne, 1998, Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease, Eur Heart J, 19, 514, 10.1053/euhj.1997.0777 Rychik, 1991, Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure, Am J Cardiol, 68, 819, 10.1016/0002-9149(91)90667-A Rothman, 1991, Protein-losing enteropathy following the Fontan operation: Resolution with prednisone therapy, Am Heart J, 121, 618, 10.1016/0002-8703(91)90743-2 Donnelly, 1997, Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation, J Pediatr, 130, 474, 10.1016/S0022-3476(97)70214-2 Murch, 1996, Congenital enterocyte heparin sulphate deficiency with massive albumin loss, secretory diarrhea, and malnutrition, Lancet, 347, 1299, 10.1016/S0140-6736(96)90941-1 Westphal, 2000, Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation, Am J Pathol, 157, 1917, 10.1016/S0002-9440(10)64830-4 Freeze, 1998, Disorders in protein glycosylation and potential therapy: Tip of an iceberg?, J Pediatr, 133, 593, 10.1016/S0022-3476(98)70096-4 Mertens, 1994, Effect of percutaneous fenestration of the atrial septum on protein-losing enteropathy after the Fontan operation, Br Heart J, 729, 591, 10.1136/hrt.72.6.591 Rychik, 1997, Late surgical fenestration for complications after the Fontan operation, Circulation, 96, 33, 10.1161/01.CIR.96.1.33 Bridges, 1995, Cardiac catheterization and test occlusion of the interatrial communication after the fenestrated Fontan operation, J Am Coll Cardiol, 25, 1712, 10.1016/0735-1097(95)00055-9 Hijazi, 1992, Hemodynamic evaluation before and after closure of fenestrated Fontan. An acute study of changes in oxygen delivery, Circulation, 86, 196, 10.1161/01.CIR.86.1.196 Mavroudis, 1992, Fenestrated Fontan with delayed catheter closure. Effects of volume loading and baffle fenestration on cardiac index and oxygen delivery, Circulation, 86, II-85 Yang, 1999, Rate of spontaneous closure of fenestration in the modified Fontan operation, Circulation, 100, I399 Cohen, 2001, Atrial pacing: An alternative treatment for protein-losing enteropathy after the Fontan operation, J Thorac Cardiovasc Surg, 121, 582, 10.1067/mtc.2001.110681 de Leval, 1988, Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience, J Thorac Cardiovasc Surg, 96, 682, 10.1016/S0022-5223(19)35174-8 Marcelletti, 2000, Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multicenter experience, J Thorac Cardiovasc Surg, 119, 340, 10.1016/S0022-5223(00)70190-5 Wilkinson, 1965, Reversible protein-losing enteropathy with intestinal lymphangiectasia secondary to chronic constrictive pericarditis, N Engl J Med, 273, 1178, 10.1056/NEJM196511252732202 Davidson, 1961, Protein losing gastroenteropathy in congestive heart failure, Lancet, 1, 899, 10.1016/S0140-6736(61)91768-8 Moodie, 1976, Transient protein-losing enteropathy secondary to elevated caval pressures and caval obstruction after the Mustard procedure, J Thorac Cardiovasc Surg, 72, 379, 10.1016/S0022-5223(19)40064-0 Shachar, 1982, Rest and exercise hemodynamics after the Fontan procedure, Circulation, 65, 1043, 10.1161/01.CIR.65.6.1043 Driscoll, 1986, Exercise tolerance and cardiorespiratory response to exercise after the Fontan operation for tricuspid atresia or functional single ventricle, J Am Coll Cardiol, 7, 1087, 10.1016/S0735-1097(86)80227-3 Gewillig, 1990, Exercise responses in patients with congenital heart disease after Fontan repair: Patterns and determinants of performance, J Am Coll Cardiol, 15, 1424, 10.1016/S0735-1097(10)80034-8 Farrell, 1992, Outcome and assessment after the modified Fontan procedure for hypoplastic left heart syndrome, Circulation, 85, 116, 10.1161/01.CIR.85.1.116 Kelley, 1995, Diminished venous vascular capacitance in patients with univentricular hearts after the Fontan operation, Am J Cardiol, 76, 158, 10.1016/S0002-9149(99)80049-6 Hsia, 2001, Subdiaphragmatic venous hemodynamics in the Fontan circulation, J Thorac Cardiovasc Surg, 121, 436, 10.1067/mtc.2001.112527 Haglund, 1987, On the pathophysiology of intestinal ischemic injury. Clinical review, Acta Chir Scand, 153, 321 Porter, 1989, Splanchnic vasospasm in circulatory shock, 73 Reilly, 1993, Vasoactive mediators and splanchnic perfusion, Crit Care Med, 21, S55, 10.1097/00003246-199302001-00011 Zelis, 1981, Cardiocirculatory dynamics in the normal and failing heart, Annu Rev Physiol, 43, 455, 10.1146/annurev.ph.43.030181.002323 Katz, 2000, Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management, 121 Yang, 1999, Mesenteric blood flow patterns after Fontan operation: A link to the development of protein losing enteropathy?, Circulation, 100, I671 Taylor, 1985, Blood flow in deep abdominal and pelvic vessels: Ultrasonic pulsed-Doppler analysis, Radiology, 154, 487, 10.1148/radiology.154.2.3880913 Taylor, 1990, Blood flow in the superior mesenteric artery: Estimation with Doppler ultrasound, Radiology, 174, 15, 10.1148/radiology.174.1.2403677 Von Oostayen, 1997, Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: Correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces, AJR Am J Roentgenol, 168, 429, 10.2214/ajr.168.2.9016220 Hjortdal, 2000, Neurohormonal activation late after cavopulmonary connection, Heart, 83, 439, 10.1136/heart.83.4.439 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Packer, 1992, The neurohumoral hypothesis: A theory to explain the mechanism of disease progression in heart failure, J Am Coll Cardiol, 20, 248, 10.1016/0735-1097(92)90167-L Lagrand, 1999, C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?, Circulation, 100, 96, 10.1161/01.CIR.100.1.96 Feldman, 2000, The role of tumor necrosis factor in the pathophysiology of heart failure, J Am Coll Cardiol, 35, 537, 10.1016/S0735-1097(99)00600-2